Mesoblast and NIH partner on 120-patient trial to treat end-stage heart failure
Australia-based regenerative medicine company Mesoblast has signed an agreement with the US National Institutes of Health's (NIH) National Heart, Lung and Blood Institute to...
Fabtech Launches Three New Products
Fabtech has launched three new products: the Sampling Booth, Mist Shower, and Discharge Collection with flame-proof execution. The Sampling Booth has been designed to...
EU approves Roche’s Avastin for platinum-resistant recurrent ovarian cancer
First new treatment option for women in Europe in more than 15 years for most difficult to treat form of ovarian cancer Roche (SIX:...
Bristol-Myers Squibb and Allied Minds form new research enterprise
Bristol-Myers Squibb and Allied Minds have formed a new jointly owned enterprise, Allied-Bristol Life Sciences, aimed at advancing discoveries of biopharmaceutical innovations at leading...
FDA approves Jardiance tablets for type 2 diabetes
The US Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) tablets, developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company, as an...
Patheon Now Working as One with DSM Fine Chemicals and Banner Life Sciences
Patheon has long been a trusted partner for the development and manufacture of high-quality pharmaceutical drug products. Now we have joined with DSM Pharmaceutical...
Patheon Now Working as One with DSM Fine Chemicals and Banner Life Sciences
Patheon has long been a trusted partner for the development and manufacture of high-quality pharmaceutical drug products. Now we have joined with DSM...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...